human | Q5 |
P6178 | Dimensions author ID | 01061043213.48 |
P2798 | Loop ID | 385740 |
P496 | ORCID iD | 0000-0003-4440-4309 |
P3829 | Publons author ID | 1250264 |
P1053 | ResearcherID | C-4945-2009 |
P734 | family name | Greer | Q16870300 |
Greer | Q16870300 | ||
Greer | Q16870300 | ||
P735 | given name | Judith | Q5954149 |
Judith | Q5954149 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q37435137 | A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis. |
Q63535316 | A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire |
Q63535314 | An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis |
Q45036480 | An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population |
Q27012075 | Autoimmune T-cell reactivity to myelin proteolipids and glycolipids in multiple sclerosis |
Q48886486 | CTLA-4 single-nucleotide polymorphisms in a Caucasian population with schizophrenia. |
Q60731232 | Characterization of a new rat model for chronic inflammatory demyelinating polyneuropathies |
Q52150778 | Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: Effect on outcome. |
Q63535323 | Comparison of T suppressor factors from tumour-bearing mice and mice immunized with a monoclonal anti-idiotypic antibody |
Q46056898 | Correlation of adrenomedullin gene expression in peripheral blood leukocytes with severity of ischemic stroke. |
Q63535318 | Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis |
Q63535320 | Distinctive molecular markers and biological activities in two tumour-specific murine T suppressor factors |
Q57693313 | Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151 |
Q63535321 | Effects of anti-idiotype vaccine on tumour growth and on production of soluble factors modulating cell-mediated immunity in vitro |
Q50654275 | Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia. |
Q34472020 | Gene expression in the spinal cord in female lewis rats with experimental autoimmune encephalomyelitis induced with myelin basic protein |
Q63535312 | Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice |
Q63535319 | Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice |
Q82849874 | Immune activation in the peripheral blood of patients with acute ischemic stroke |
Q28303348 | Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? |
Q63535313 | Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein |
Q50766428 | Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain-Barré syndrome. |
Q78608096 | Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis |
Q63535310 | Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis |
Q63535124 | Increased constitutive activation of NF-κB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosis |
Q53118085 | Investigation of the [-/A]8 and C1236T genetic variations within the human Toll-like receptor 3 gene for association with multiple sclerosis. |
Q92196062 | Is there a role for antibodies targeting muscarinic acetylcholine receptors in the pathogenesis of schizophrenia? |
Q63535271 | Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke |
Q37172971 | Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis. |
Q45842759 | Novel Therapeutics for Multiple Sclerosis Designed by Parasitic Worms. |
Q49032270 | Orientation of myelin proteolipid protein in the oligodendrocyte cell membrane |
Q57476157 | PLP1 Mutations in Patients with Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations |
Q50644184 | Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis. |
Q47687532 | Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis. |
Q45845904 | Quantitative proteome profiling of CNS-infiltrating autoreactive CD4+ cells reveals selective changes during experimental autoimmune encephalomyelitis. |
Q33645752 | Reactivity to Novel Autoantigens in Patients with Coexisting Central Nervous System Demyelinating Disease and Autoimmune Thyroid Disease |
Q98384953 | Reduced IκB-α Protein Levels in Peripheral Blood Cells of Patients with Multiple Sclerosis-A Possible Cause of Constitutive NF-κB Activation |
Q37862835 | Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms |
Q37595548 | Sexual dimorphism in autoimmune disease. |
Q51789015 | Studies of HLA associations in male and female patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). |
Q51793107 | Study of leukemia inhibitory factor polymorphism within an Australian multiple sclerosis population. |
Q38477340 | Taming the TCR: antigen-specific immunotherapeutic agents for autoimmune diseases |
Q38287223 | The Role of HLA in MS Susceptibility and Phenotype |
Q33804295 | The effect of ageing on human lymphocyte subsets: comparison of males and females |
Q35487679 | The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosis |
Q28389137 | The role of epigenetic mechanisms and processes in autoimmune disorders |
Q63535217 | Thiopalmitoylation of Altered Peptide Ligands Enhances Their Protective Effects in an Animal Model of Multiple Sclerosis |
Search more.